You searched for Antibody candidate - Page 13 of 69

Best in Biotech 14 Mar 2024

7 oncolytic virus companies you should know about

…it has developed an extensive library of isolated and engineered oncolytic vaccinia virus (a poxvirus similar to smallpox) immunotherapeutic product candidates. The oncolytic virus company’s most advanced candidate, Olvi-Vec (olvimulogene…

March 14, 2024 - 8 minutesmins - By Willow Shah-Neville

Best in Biotech 21 Dec 2023

Five companies racing to bring their NASH treatments toward the finish line

…Drug Administration (FDA)-approved treatments for the disease, many NASH companies are currently attempting to bring their candidates toward approval. In this article, we take a look at five of the…

December 21, 2023 - 7 minutesmins - By Willow Shah-Neville

Best in Biotech 15 Aug 2024

10 neuroscience biotech companies you should know about

…focused on developing the first oral treatment with the potential to slow or stop the progression of Alzheimer’s disease. Its candidate is called ALZ-801 and is currently in phase 3…

August 15, 2024 - 12 minutesmins - By Willow Shah-Neville

In Depth 23 Apr 2025

The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval

…exclusive rights to the candidate in the field of multiple sclerosis worldwide and certain other autoimmune diseases outside of China. Biogen did not specify why it had dropped the candidate…

April 23, 2025 - 9 minutesmins - By Willow Shah-Neville

News and Trends 31 Oct 2018

Multiple Myeloma Antibody Therapy Achieves Positive Phase III Results

An antibody therapy for the blood cancer multiple myeloma achieved positive results at Phase III, decreasing the risk of the disease getting worse and patient death by 45% in a…

October 31, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 20 Jul 2023

Mage Biologics created to develop oral antibody therapy for ulcerative colitis

…(PFC) investment for TVM LSI II. Mage Biologics plans to advance to clinical proof of concept a novel, orally administered, humanized monoclonal antibody (mAb) bioengineered for optimal potency and tissue…

July 20, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 12 Jan 2017

Antibody Treatment for Obesity and Type 2 Diabetes enters Phase II

Novartis is initiating Phase II trials with an antibody licensed from German biotech MorphoSys that tackles the obesity and diabetes epidemic. MorphoSys is a billion euro biotech that develops therapeutic…

January 12, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Oct 2022

WuXi Biologics and Toregem BioPharma to develop antibody for adentia treatment

…Takahashi investigated the effects of a monoclonal antibody for USGA-1. His experiments with this antibody revealed that BMP/Wnt signaling was critical for determining the number of teeth in mice, and…

October 12, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 19 Apr 2016

GSK goes to phase II with German Antibody for Inflammatory Diseases

GSK has started a phase II trial for inflammatory hand osteoarthritis, with a candidate originally from MorphoSys‘ antibody library. GSK, a big UK Pharma, has announced the start of a…

April 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 29 Jun 2022

Watch: Antibody Analytics opens new health sciences center

A new facility dedicated to the advancement of medical research and drug development opened its doors recently in Motherwell, Scotland, as part of a major expansion. Antibody Analytics, one of…

June 29, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 23 Oct 2017

Swiss Biotech Rakes in $200M to Accelerate Antibody-based Cancer Treatments

ADC Therapeutics has received massive private funding to progress two of its lead candidates for cancer through clinical trials. ADC Therapeutics, based in Lausanne, Switzerland, specializes in developing antibody-drug conjugates…

October 23, 2017 - 3 minutesmins - By Alex Dale

News and Trends 24 Feb 2017

What are the Current Challenges in the Booming Field of ADCs?

…carboxylic acids on an antibody. Another linker-related problem in ADC development is the drug-antibody ratio (DAR): it’s difficult to pin an exact number of toxins to an antibody and even…

February 24, 2017 - 5 minutesmins - By Evelyn Warner

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

7 oncolytic virus companies you should know about

Five companies racing to bring their NASH treatments toward the finish line

10 neuroscience biotech companies you should know about

The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval

Multiple Myeloma Antibody Therapy Achieves Positive Phase III Results

Mage Biologics created to develop oral antibody therapy for ulcerative colitis

Antibody Treatment for Obesity and Type 2 Diabetes enters Phase II

WuXi Biologics and Toregem BioPharma to develop antibody for adentia treatment

GSK goes to phase II with German Antibody for Inflammatory Diseases

Watch: Antibody Analytics opens new health sciences center

Swiss Biotech Rakes in $200M to Accelerate Antibody-based Cancer Treatments

What are the Current Challenges in the Booming Field of ADCs?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!